Efficacy of <i>Saccharomyces boulardii</i> CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19

Efficacy of <i>Saccharomyces boulardii</i> CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19

Aim. To evaluate the efficacy of Saccharomyces boulardii (S. boulardii) CNCM I-745 probiotic drug in preventing and treating diarrhea in hospitalized patients with COVID-19. Materials and methods. A prospective comparative study was conducted in two parallel groups. The study included males and f...

Full description

Bibliographic Details
Main Authors: Igor V. Maev, Dmitry N. Andreev, Philipp S. Sokolov, Aleksei К. Fomenko, Mikhail K. Devkota, Nikolai G. Andreev, Andrew V. Zaborovsky
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2022-11-01
Series:Терапевтический архив
Subjects:
coronavirus
covid-19
sars-cov-2
gi tract
diarrhea
saccharomyces boulardii
s. boulardii cncm i-745
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/114789/89570

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/114789/89570

Similar Items